New imaging technique to study cancer cell metabolism
Bio-orthogonal Mid-Infrared Photothermal Imaging of Cancer Metabolism
['FUNDING_OTHER'] · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · NIH-10917502
This study is exploring how cancer cells behave and change their energy use, and it's designed for cancer patients to help develop a new imaging technique that lets doctors see what's happening inside tumors in real-time, which could lead to better ways to diagnose and treat cancer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10917502 on ClinicalTrials.gov |
What this research studies
This research investigates how cancer cells change their metabolism and interact with their environment, which can lead to more aggressive behavior or resistance to treatments. The team aims to develop a novel imaging technique called bio-orthogonal mid-infrared photothermal imaging, which allows for real-time observation of cancer metabolism without damaging the cells. By using specialized probes, this method seeks to provide detailed insights into the chemical processes occurring within tumors, potentially leading to improved diagnostic and treatment strategies for cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with various types of cancer who are undergoing treatment or monitoring.
Not a fit: Patients with non-cancerous conditions or those not currently receiving treatment for cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the understanding of cancer metabolism, leading to better diagnostic tools and more effective treatments for cancer patients.
How similar studies have performed: While the approach of using mid-infrared imaging is innovative, similar techniques in cancer metabolism research have shown promise, indicating potential for success.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHENG, JI-XIN — BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
- Study coordinator: CHENG, JI-XIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers